Trials / Recruiting
RecruitingNCT05862454
Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise
Magnesium Injection Ensures Analgesia and Steroid Avoidance During Vaccination, Viremia or Immunocompromise
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Salem Anaesthesia Pain Clinic · Academic / Other
- Sex
- All
- Age
- 20 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Steroid injections are used for interventional pain management. However, their side-effect of immunosuppression may increase the risk of infections. Magnesium is an alternative anti-nociceptive injection that may be used instead of steroids. Prospective observational study of patients who received magnesium injection for interventional pain therapy, instead of steroid injection. Post-injection data collection includes numerical rating pain score, and sleep quality score. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.
Detailed description
Corticosteroid injections are used for interventional pain management. The immunosuppression effect of steroid injection may increase the risk of infections. Magnesium is an alternative anti-nociceptive agent that may be used for interventional pain injection therapy, instead of steroids. Prospective observational clinical study of pain clinic patients who received magnesium injection for interventional pain therapy, instead of steroid injection. Post-injection data collection includes numerical rating pain score, and sleep quality score. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant. Data analyzed with IBM® SPSS® Statistics 25 (IBM Corp, Armonk, NY); using Student's t-test, ANOVA, Pearson Chi-square test, and regression analysis. P-value \<0.05 is considered significant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium | Magnesium injection therapy |
Timeline
- Start date
- 2020-07-02
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-05-17
- Last updated
- 2025-01-27
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05862454. Inclusion in this directory is not an endorsement.